295
Participants
Start Date
December 31, 2025
Primary Completion Date
April 30, 2027
Study Completion Date
March 31, 2029
LY4152199 - IV
Administered by IV infusion
LY4152199 - SC
Administered by SC injection
Center for Cancer and Organ Diseases - Rigshospitalet, Copenhagen
Peter MacCallum Cancer Centre, East Melbourne
The Alfred Hospital, Melbourne, VIC
Linear Clinical Research, Nedlands
New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
South Texas Accelerated Research Therapeutics (START) Madrid - Hospital Fundacion Jimenez Diaz, Madrid
SCRI Oncology Partners, Nashville
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant Orsola, Bologna
Cleveland Clinic, Cleveland
Universitaetsklinikum Muenster, Münster
University of Iowa, Iowa City
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Mayo Clinic - Rochester, Rochester
CHU de Lille - Hopital Claude Huriez, Lille
The University of Chicago Medical Center (UCMC), Chicago
University of Kansas Cancer Center, Kansas City
University of Texas Southwestern, Dallas
MD Anderson Cancer Center, Houston
Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli
Colorado Blood Cancer Institute, Denver
LMU Klinikum Muenchen-Campus Grosshadern, München
City of Hope, Duarte
Swedish Cancer Institute (SCI), Seattle
University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
Yale University School of Medicine - Yale Cancer Center, New Haven
Dana-Farber Cancer Institute, Boston
Rutgers Cancer Institute of New Jersey, New Brunswick
University Health Network (UHN) - Princess Margaret Cancer Centre, Toronto
National Cancer Center Hospital East, Chiba
Cancer Institute Hospital of JFCR, Tokyo
Pratia MCM Krakow, Krakow
AIDPORT Sp. z o.o., Skorzewo
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Hospital Universitario Vall d'Hebron, Barcelona
Institut Catala d'Oncologia - L'Hospitalet, Barcelona
Leeds Teaching Hospitals NHS Trust, Leeds
Oxford University Hospitals NHS Foundation Trust, Oxford
Eli Lilly and Company
INDUSTRY